Cascade Biocatalysts, Inc. research brief
CIK 2083126
Generated Nov. 19, 2026, 1:19 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: DENVER Colorado. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 25, 2025 · D · 0001231919-25-000162 · Source evidence
Reported offering amount: 5616959 USD. Reported amount sold: 5441785 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Cascade Biocatalysts, Inc. research brief,” CIK 2083126, retrieved Nov. 19, 2026, 1:19 a.m.. Cite the specific accessions used. No amounts have been summed.